DOI: http://dx.doi.org/10.18203/2349-3933.ijam20173224

The study of plasma homocysteine level as a risk factor for ischemic strokes in young patients

Prashant T. Gajbhare, Nazir I. Juvale

Abstract


Background: According to the WHO, stroke is second leading cause of death for people above the age of 60 years & fifth leading cause in people aged 15 to 59 years old. Each year, nearly six million people worldwide die from stroke. One in six people worldwide will have a stroke in their lifetime. Approximately one-quarter of 45-year-old men will have a stroke before they reach the age of 85. Stroke is also important condition in young people and can occur at any age, including in utero, neonatal period (it is the major cause of cerebral palsy), childhood and young adult life. One-quarter of all strokes occur in people below the age of 65.

Methods: This prospective observational case control study was carried on 30 young ischemic stroke patients with 30 control match persons over a period of 20 months, from December 2011 to August 2013 at Tertiary Care Hospital Grant Government Medical College and Sir JJ Group of Hospitals, Mumbai, India.

Results: Total plasma fasting homocysteine level in case group was 30.10±14.8 µmol/L and control group was 13±5.3 µmol/L, (p=0.001). Elevated fasting homocysteine level was found in 76.66. 0% of ischemic stroke cases and in 10% of healthy controls (p=0.001). Serum homocysteine levels were higher in subjects having risk factors such as dyslipidemia (p value <0.001), active lifestyle (p value <0.05) and smoking (p value<0.05). Serum homocysteine did not show any significant relation with age, sex, diabetes mellitus, diet pattern and defective coagulation (p value >1).

Conclusions: The present study revealed that hyperhomocysteinemia appears to be an important risk factor for young ischemic strokes. It is therefore important to use serum homocysteine level as an important tool to investigate all cases of young ischemic strokes and also in those who are at risk of developing it. Significant correlation has been found between homocysteine concentration and young ischemic strokes.


Keywords


Hyperhomocysteinemia, Ischemic Stroke, Young age

Full Text:

PDF

References


WHO Stroke Fact sheet: 2012. Available at "http://www.who.int/en/%20%20cerebrovascular"www.who.int/en/ cerebrovascular accident, http://www.who.int/chp/steps/stroke/en/" www.who.int/chp/steps/stroke/en/apps.who.int/infobase/Mortality. Accessed on 20 January 2013.

Park’s Textbook of Preventive and Social Medicine 20th Edition; 2009:328-511.

Biswas T. India unveils plans to improve stroke research and care. Available at www.thelancet.com/journals/lancet/articlePIIS0140-6736(13)60073-/fulltext. Accessed on 27 June 2013.

Pinto A. Cerebrovascular risk factors and clinical classification of strokes. Semin Vasc Med. AUG;4(3):287-303. Dept. of Internal Medicine and Cardioangiology, University of Palermo, Palermo, Italy. Available at www.ncbi.nlm.nih.gov. /m/pubmed/ 15630637 Accessed on 28 June 2013. Harrison’s Principles of Internal Medicine. 18 edition, chapter 370: 2047,2970, 3070-3299,3600

Satyanarayana's U. Textbook of Biochemistry 3rd Edition; 2007:360-361.

Homocysteine: Fact sheet, 2013. Available at http://en.wikipedia.org/wiki/Homocysteine. Assesed on 28 June 2013.

Selhub J, Jacques PF, Bostom AG, D’Agostino RB, Wilson PWF, Belanger AJ, et al. Association between plasma homocysteine concentrations and extra cranial carotid-artery stenosis. N Engl J Med. 1995;332:286-91.

Boysen G, Brander T, Christensen H, Gideon R, Truelsen T. Homocysteine and risk of recurrent stroke. Stroke. 2003;34(5):1258-61.

Perry IJ. Homocysteine, hypertension and stroke. J Human Hypertens. 1999;13:289-93.

Tan NC, Venketasubramanian N, Saw SM, Tjia HT. Hyperhomocyst (e) inemia and risk of ischemic stroke among young Asian adults. Stroke. 2002;33(8):1956-62.

Mojiminiyi OA, Marouf R, Al Shayeb AR, Qurtom M, Abdella NA, Al Wazzan H, et al. Determinants and associations of homocysteine and prothrombotic risk factors in Kuwaiti patients with cerebrovascular accident. Med Principles Pract. 2008;17(2):136-42.

Brattstrom LE, Hardebo JE, Hultberg BL. Moderate homocysteinemia: a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke. 1984;15:1012-6.

Narang, APS, Verma I, Kaur S, Narang A, GuptaS, Avasthi G. Homocysteine- Risk factor for ischemic stroke?. Indian J Physiol Pharmacol. 2009;53(1):34-8.

Modi M, Prabhakar S, Majumdar S. Hyperhomocysteinemia as a risk factor for ischemic stroke: an Indian scenario. Neurol India. 2005;53(3):297-302.

Zongte Z, Shaini L, Gyaneshwar WS et al. Serum homocysteine levels in cerebrovascular accidents. Indian J Clinical Biochem. 2008;23(2):154-7.

Kang SS, Wong PWK, Cook HY et al. Protein-bound homocysteine: A possible risk factor for coronary artery disease. J Clin Invest. 1986;77:1482-6.

Nygard O, Vollset SE, Refsum H. Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine Study. JAMA 1995;274:1526­33.

Welch GN, Loscalzo J. Homocysteine and atherothrombosis. N Engl J Med. 1998;338:1042-50.

Roudbari SA, Amini A. Survey homocysteine serum level in CVA ischemic infarct patients. J Guilan University of Medical Sciences Fall. 2006;15(59):20-5.

Perry IJ, Morris RW, Ebrahim SB, Shaper AG, Refsum H, Ueland PM. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. The Lancet. 1995;346(8987):1395-8.

Kittner SJ, Giles WH, Macko RF, Hebel JR, Wozniak MA, Wityk RJ, et al. Homocyst (e) ine and Risk of Cerebral Infarction in a Biracial Population. Stroke. 1999;30(8):1554-60.

Graham IM, Daly LE, Refsum HM, Robinson K, Brattström LE, Ueland PM, et al. Plasma homocysteine as a risk factor for vascular disease. Eu Concerted Act Proj Jama. 1997;277(22):1775-82.

Malinow MR, Nieto FJ, Szklo M, Chambless LE, Bond G. Carotid artery intimal-medial wall thickening and plasma homocyst (e) ine in asymptomatic adults. Atherosclerosis Risk in Communities Study. Circulation. 1993;87(4):1107-13.

Kalita J, Misra UK, Srivastava AK, Bindu IS. A study of homocysteine level in North Indian subjects with special reference to their dietary habit. Eu J Clin Nutr Metabol. 2007;2(6):e116-9.

Mouravas H. Hoppokratia. 2010;14(3):185-8.

Den Heijer M, Lewington S, Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta‐analysis of published epidemiological studies. J Thrombosis and Haemostasis. 2005;3(2):292-9.

Reis RP. Rev Port Cardiol. 2001;20(4):413-8. Available at http://www.pubmed.gov.com. Assessed on 20 April 2013.

Stampfer MJ, Malinow MR, Willett WC, Newcomer LM, Upson B, Ullmann D, et al. A prospective study of plasma homocyst (e) ine and risk of myocardial infarction in US physicians. Jama. 1992;268(7):877-81.

Joosten E, Van den Berg A, Riezler R, Naurath HJ, Lindenbaum J, Stabler SP, et al. Metabolic evidence that deficiencies of vitamin B-12 (cobalamin), folate, and vitamin B-6 occur commonly in elderly people. Am J Clin Nutr. 1993;58:468-76.

Selhub J, Jacques PF, Wilson PWF, Rush D. Vitamin status and intake as primary determinants of homocysteinaemia in an elderly population. JAMA. 1993;270:2693-8.

Verhoef P, Hennekens CH, Malinow MR, Kok FJ, Willett WC, Stampfer MJ. A prospective study of plasma homocyst (e) ine and risk of ischemic stroke. Stroke. 1994;25(10):1924-30.

Alfthan G, Pekkanen J, Jauhiainen M, Pitkäniemi J, Karvonen M, Tuomilehto J, et al. Relation of serum homocysteine and lipoprotein (a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atheroscler. 1994;106(1):9-19.

Mousavi SA, Ghasemi M, Hoseini T. Association between plasma homocysteine concentrations and extracranial carotid stenosis. Ann Saudi Med. 26:120-2.

Fujishima M. Cerebrovascular disorders among Japanese. J Jpn Soc Intern Med. 1996;85:1407-18.

Boushey CJ, Beresford SA, Omenn GS, Motulsky AG. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. Jama. 1995;274(13):1049-57.